Bio-Ker SRL
4Patents
4Active
4Granted
42Portfolio score
Filing activity: Jan 14, 2005 → Nov 4, 2009 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7893019B2 | G-CSF site-specific mono-conjugates | Human Necessities | 4 | Active |
| US7781189B2 | Catalyzing transglycosylation using a recombinant host cell overexpressing uridine phosphorylase and purine nucleoside phosphorylase | Chemistry; Metallurgy | 0 | Active |
| US8580733B2 | Site-specific monoconjugated insulinotropic GLP-1 peptides | Human Necessities | 0 | Active |
| US7410775B2 | Method for making recombinant peptides or proteins using soluble endoproteases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.